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Abstract
The bacteria inhabiting the mammalian gastrointestinal (GI) tract play a vital role in normal digestion and immune function.
In a healthy host, the immune system is tolerant to gut bacteria and does not mount an effector response to bacteria-
derived antigens. Loss of tolerance to intestinal microflora has been associated with inflammatory bowel disease (IBD) in
both mice and humans. Mice lacking Ndfip1, an adaptor protein for E3 ubiquitin ligases of the Nedd4-family, in T cells
(Ndfip1-cKO) develop a disease resembling IBD. Inflammation in these mice is characterized by increased activation of
peripheral T cells, infiltration of eosinophils into the GI tract, and epithelial hypertrophy in the esophagus. We hypothesized
that this intestinal inflammation in Ndfip1-cKO mice is caused by a loss of T-cell tolerance to bacterial antigens. Here, we
show that treatment of Ndfip1-cKO mice with broad-spectrum antibiotics drastically reduced bacterial load in stool but had
little effect on T-cell activation and did not affect eosinophil infiltration into the GI tract or epithelial hypertrophy in the
esophagus. Thus, inflammation in Ndfip1-cKO mice is not caused by a loss of tolerance to intestinal microbiota. Rather, T cell
activation and eosinophilia may instead be triggered by other environmental antigens.
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Introduction
Bacteria in the mammalian gut play a crucial role in host
homeostasis, aid digestion, provide competitive barriers to
pathogen invasion, and contribute to immune system development
[1]. While the intestinal immune system is capable of mounting a
rapid effector response to pathogenic bacteria, it is tolerant toward
gastrointestinal microflora and does not normally mount an
immune response against bacteria-derived antigens [2]. A loss of
tolerance to gastrointestinal bacteria has been implicated in the
pathogenesis of many mucosal diseases, including inflammatory
bowel disease (IBD) [2–5].
It was recently shown that mice deficient in Nedd4-family
interacting protein-1 (Ndfip1) develop IBD-like symptoms [3].
Ndfip1 is an adaptor for E3 ubiquitin ligases of the Nedd4-family,
including Itch. Itch can promote ubiquitin-mediated degradation
of various signaling proteins, thereby suppressing T cell activation
and inflammation [4]. Ndfip1 has been shown to promote Itch
function in vivo. For example, Ndfip1 promotes Itch ubiquityla-
tion and subsequent degradation of JunB, a transcription factor
that increases production of proinflammatory TH2 cytokines
interleukin (IL)-4 and IL-5. In the absence of Ndfip1, JunB
accumulates and promotes TH2 cytokine transcription [5]. Mice
lacking Ndfip1 develop severe TH2-mediated inflammation at sites
of environmental antigen exposure, including skin, GI tract, and
lung. GI inflammation in Ndfip12/2 mice is preceded by
aberrant activation of CD4+ and CD8+ T cells and increased IL-5
production, followed by recruitment of eosinophils into the GI
tissue [3]. Transfer of Ndfip12/2 CD4+ T cells is sufficient to
induce GI inflammation in Rag12/2 mice [3]. Additionally,
mice lacking Ndfip1 only in T cells (referred to here as Ndfip1
cKO mice) develop GI tract symptoms similar to those observed in
Ndfip12/2 mice [6]. These observations suggest that, in the
absence of Ndfip1, aberrant T-cell responses drive eosinophil
recruitment and inflammation in the GI tract.
The localization of inflammation in Ndfip12/2 mice to sites of
environmental antigen exposure suggests loss of tolerance to
environmental antigens. Thus, we hypothesized that GI inflam-
mation in Ndfip12/2 mice is caused by an inappropriate T-cell
response to gastrointestinal microbiota. In several genetic models
of IBD, depletion of intestinal bacteria by oral antibiotic treatment
greatly reduces intestinal inflammation [7,8,9]. We therefore
tested the role of bacterial antigens in triggering the Ndip12/2
phenotype by treating Ndfip1 cKO mice with a cocktail of
antibiotics and subsequently analyzing tissues for signs of
inflammation in the GI tract.
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Mice
Ndfip1-cKO mice have been described [6]. All experiments
described in this manuscript compare Ndfip1-cKO mice to
littermate controls. These controls include mice with one or two
Ndfip1 floxed alleles but not expressing Cre, or mice expressing
Cre that do not have either Ndfip1 allele floxed. No differences
were observed when comparing these two types of controls. All
mice were bred in the Children’s Hospital of Philadelphia animal
facility. All experimentation was approved and followed guidelines
established by the institutional animal care and use committee of
the Children’s Hospital of Philadelphia.
Genotyping
Ndfip1-cKO mice were genotyped using purified genomic DNA
from tail samples and the following PCR primers: Ndfip1 floxed
forward 59-TGAGGAAACAGACACACAATG-39, Ndfip1 floxed
reverse 59- TGGAATGAACCTGAGGTCTCC-39. Samples were
amplified using conventional PCR techniques and run by
electrophoresis on a 1% agarose gel. Wild type DNA forms an
approximately 1 kb band and Ndfip12/2 DNA yields an
approximately 340 bp band.
Antibiotics
Animals were provided with autoclaved drinking water supple-
mented with sucralose (1.5 mgmL
21) or autoclaved drinking water
supplemented with sucralose(1.5 mgml
21),ampicillin(0.5 mgml
21),
gentamicin (0.5 mgml
21), metronidazole (0.5 mgml
21), neomycin
(0.5 mgml
21) and vancomycin (0.5 mgml
21). For mice treated upon
weaning, animals were26 days old at the start of treatment and were
sacrificed 14 days later. For mice treated since birth, pregnant
femaleswere treatedstartingapproximately1daybeforegiving birth
until their litters were weaned, at which point weaned pups were
treated for a further 14 days and sacrificed.
Lymphocyte isolation from tissues
At necropsy, mesenteric lymph nodes (mLN), spleen, esophagus
and small bowel were harvested. Single-cell suspensions of spleen
and mLN were prepared by mashing tissue through a 70 mm filter.
LNs were then washed and resuspended in phosphate-buffered
saline (PBS). Splenic red blood cells were lysed with ACK buffer
(.15 M Nh4Cl, 10 mM KHCO3, .1 mM EDTA) and samples
were then washed and resuspended in PBS.
For preparation of lymphocytes from the small bowel, a 3–4
inch section of small bowel was removed. Peyer’s patches were
excised and the luminal contents were removed.
Small bowel and esophagus samples were minced and then
digested in medium containing collagenase type 1, collagenase
type 1a, and DNAse for approximately one hour at room
temperature. Samples were then strained through a 100 mm filter,
washed with Dulbecco’s Modified Eagle Media (DMEM), and
filtered again through a 40 mm filter.
Flow Cytometry
Single-cell suspensions of lymphocytes isolated from tissues were
stained for surface expression using fluorochrome conjugated anti-
CD3, anti-CD8a, anti-CD8b, anti-CD4, anti-F4/80, anti-CD62L,
anti-CD44, and anti-Siglec-F (anti-Siglec-F was purchased from
BD Biosciences; all other antibodies were purchased from
Biolegend). Cells were stained for 30 minutes on ice and washed
twice with PBS containing fetal calf serum and sodium azide
(FACS buffer). Flow cytometry was performed on an LSRFortessa
flow cytometer (BD Biosciences) and results were analyzed using
Flow-Jo software (Treestar USA).
Histological Analysis
At necropsy, small bowel and esophagus sections were removed,
fixed in 10% formalin for 48 hours, and embedded in paraffin.
Sections were stained with eosin and hematoxyin. Stained sections
were analyzed using a Leica microscope (Bannockburn, IL) with a
bright field objective.
DNA Extraction
Stool samples were collected on day 0 of the experiment prior to
sucralose or antibiotic administration and on day 13 (for mice
treated upon weaning) or day 34 (for mice treated since birth).
Samples were stored at 280 C and later defrosted and lysed by
bead beating using the Mini BeadBeater-16 (Biospec). The samples
were then prepared using the QiaAmp DNA Stool Mini Kit
(Qiagen) according to the manufacturer’s instructions. Final DNA
concentrations were measured using a Thermo Nanodrop 2000.
Bacterial quantitation by 16S qPCR
16S quantitation was performed using real-time PCR of 20 uL
triplicate reactions containing 10 ng stool DNA, TaqMan
Environmental Master Mix 2.0 (Applied Biosystems), and
primers/probe specific for bacterial 16S rDNA as described by
Hill, et al. [10]. Standard curves with a range of 10
1 to 2610
7
copies of E. coli 16S rDNA were prepared using linearized plasmid
containing a single copy of the 16S gene.
Results
Ndfip1-cKO mice Display T-cell Activation and GI
Inflammation
Ndfip1-deficient mice develop a severe inflammatory disease by
6 weeks of age. However, the precise age of disease onset in mice
lacking Ndfip1 only in T lineage cells was unknown. We sought to
characterize Ndfip1-cKO mice at 3 and 5 weeks of age by testing
for T cell activation in the spleen as well as T cell and eosinophil
infiltration of the small bowel and esophagus.
Histological sections of esophagus showed increased inflamma-
tion and hypertrophy of the esophageal epithelium of Ndfip1-cKO
mice at 5 weeks of age. However, no discernible difference between
control and Ndfip1-cKO mice was observed at 3 weeks (Figure 1A).
Flow cytometric analysisofcellsisolated from the esophagusshowed
an increased percentage of Siglec F+ cells in Ndfip1-cKO mice by 5
weeks of age. In contrast, the percentage of eosinophils in the
esophagus of 3 week old Ndfip1-cKO mice was not as profound
(Figure 1B). Similarly, an increase in the percentages of eosinophils
in the small bowel of Ndfip1 cKOs was observed at 5 weeks, but this
was not as evident at 3 weeks-of-age (Figure 1C). Spleens of Ndfip1
cKO mice are typically enlarged 2–3 fold compared with wild-type
littermates. Average total spleen cellularity was 101610
6 cells for 3-
week-old Ndfip1 cKO animals compared to 40610
6 for 3 –week-
old controls. By five weeks of age the total numbers of cells isolated
from the spleens of Ndfip1-cKO mice had increased further, to an
average of 124610
6. Because of this increase in cellularity, we
compared differences in activation of splenic T cells in 3 and 5 week
old mice. As shown previously, T cells lacking Ndfip1 are more
likely to have a previously activated phenotype, characterized by
increased levels of CD44, than control T cells. Interestingly, flow
cytometry analysis showed a similar increase in CD4+ T cell
activation at both 3 and 5 weeks of age (Figure 1D). Similar results
were observed in CD8+ T cells isolated from the spleen (data not
shown).
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that contain T cells specific for an ovalbumin peptide that is not
expressed in mice (OTII), T cells maintain a naı ¨ve phenotype [6].
Thus, T cells lacking Ndfip1 must be exposed to antigen(s) to acquire
an activated phenotype. Taken together,these data suggest that T cells
lacking Ndfip1 become activated by antigens and then migrate into
the GI tract where they drive inflammation. Knowing that bacterial-
derived antigens are a major source of antigens in the GI tract, we
hypothesized that these antigens might promote the activation of T
cells lacking Ndfip1 and thus drive GI inflammation in the GI tract.
Antibiotic Treatment of WT Mice Reduces Intestinal
Bacteria and Does Not Significantly Alter T cell Activation
or GI Eosinophilia
While oral administration of a broad-spectrum cocktail of
antibiotics in drinking water has been shown to be extremely
effective in reducing intestinal bacteria, the unpleasant taste can
cause mice to avoid drinking and lead to insufficient hydration in
treated mice [10]. To ensure effective knockdown of bacteria
without causing dehydration, we modified the antibiotic regimen
in Hill et al. [10] by reducing the concentration of antibiotics and
adding sucralose, a non-nutritive sweetener, to encourage
drinking. Control cages received drinking water with sucralose
only. As shown in Figure 2A, after 13 days this treatment regimen
reduced the amount of bacterial 16S rDNA detected in total stool
DNA by over 100-fold. In addition, although the mice receiving
antibiotics showed an initial loss of weight compared to mice
receiving only sucralose, they gained weight steadily over the
course of treatment and did not display scruffy coat, lethargy, or
other signs of dehydration (Figure 2B and data not shown).
Following treatment, we analyzed wild type mice for signs of
immunological changes caused by antibiotic treatment. Flow
Figure 1. Ndfip1-cKO mice show increased inflammation and eosinophilia between 3 and 5 weeks of age. (A–D) Ndfip1-cKO and
control mice were analyzed at 3 weeks and 5 weeks of age for signs of inflammation. Representative histology or flow plots from each group are
shown. (A) Histological sections of esophagus were taken from Ndfip1-cKO and control mice at 3 weeks and 5 weeks of age, were stained with H & E
and analyzed by microscopy using a 106objective. (B–C) Representative flow cytometric analysis of cells isolated from the esophagus (B) and small
bowel (C). Plots show CD45+, live gated cells. Eosinophils (Siglec F+ cells) and CD4+ T cells are shown. Percentages of populations in the gated
regions are indicated. Representative flow cytometric analysis of splenic CD4+ T cells (D). Gate on each plot represents cells defined as activated
based on expression of CD44 and loss of CD62L. Percentage of cells in each gate is indicated.
doi:10.1371/journal.pone.0034478.g001
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splenic CD4+ or CD8+ T cells (Figure 2C and data not shown).
Additionally, sections of the esophagus and small bowel did not
show histological changes following antibiotic treatment
(Figure 2D–E).
Antibiotic Treatment of Ndfip1-cKO mice from 3–5
Weeks of Age Does Not Reduce Inflammation
We next treated age-matched pairs of Ndfip1-cKO and control
mice with oral antibiotics as described above. Similar to the results
seen in WT mice, antibiotic treatment was extremely effective in
reducing bacterial DNA detected in stool and did not cause weight
loss (Figure 3A–B). Furthermore, no significant differences were
seen in the total amounts of bacteria, as determined by comparing
the concentration of 16 s rDNA between Ndfip1-cKO mice and
controls, between the two genotypes either before or after
antibiotic treatment (data not shown). Despite drastically reducing
bacterial flora, antibiotic treatment of Ndfip1-cKO animals did
not produce any discernible decrease in inflammation of the
esophagus or small bowel. For example, we did not observe a
decrease in the hypertrophy in the epithelial esophagus or the
number of visible eosinophils infiltrating into the villi of the small
bowel following treatment with antibiotics (Figure 3C). Further-
more, flow cytometry revealed no significant change in the
percentages of activated CD4+ T cells isolated from the spleen or
mesenteric lymph nodes following antibiotic treatment (Figure 3D
and data not shown).
Antibiotic Treatment of Ndfip1-cKO Mice from Birth to 5
Weeks of Age Does Not Reduce T cell activation or GI
Tract Inflammation
Because Ndfip1-cKO mice begin to show signs of T cell
activation and eosinophilic infiltration into the GI tract as early as
three weeks of age, we wondered whether administration of
antibiotics beginning at 3 weeks was too late. We hypothesized
that treatment from birth would be more effective in reducing
pathology. To test this, we administered broad-spectrum antibi-
otics to pregnant females beginning 1 day prior to their expected
delivery date as described above. Treatment continued until mice
were analyzed at 5 weeks of age. Antibiotic treatment of Ndfip1
cKO animals using this regimen resulted in similar levels of 16S
rDNA in stool at 5 weeks of age as when treatment was
administered from 3–5 weeks of age (data not shown). Important-
Figure 2. Antibiotic treatment of wild type mice decreases bacterial load and does not produce overt immunological changes. (A)
The average fold change in 16 s rDNA copies was quantified by qPCR from stool of wildtype mice treated with antibiotics and sucralose (n=5) or
sucralose alone (n=3). Data shown is the fold change in 16S copies after 13 days of treatment. Error bars represent the SD. (B) The weight of mice
treated with sucralose only (black line) or sucralose and antibiotics (dotted line) is shown over the course of treatment. Dot represents the mean of
the population and error bars are the SD from the mean. (C) Percentages of activated splenic CD4+ T cells (defined as shown in Figure 1D) in mice
treated with sucralose only or sucralose and antibiotics is shown. Each dot represents a single mouse. (D–E) Histological sections of the esophagus (D)
and small bowel (E) are shown for mice treated with sucralose only (2antibiotics) or sucralose and antibiotics (+antibiotics). A 106objective was used
for esophagus and a 406objective was used to analyze small bowel.
doi:10.1371/journal.pone.0034478.g002
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course of treatment (Figure 4A).
Similar to our observations of mice treated from 3–5 weeks of
age, we did not observe any visible reduction in inflammation
following antibiotic treatment from birth. The esophageal
epithelium of Ndfip1 cKO mice treated from birth was inflamed
compared with age-matched controls (Figure 4B). Flow cytometric
analysis of cells isolated from the esophagus and small bowel
revealed increased percentages of eosinophils in Ndfip1-cKO
compared with controls (Figure 5A–D). The representative plot in
figure 5C shows increased percentages of (Siglec F+) eosinophls
among cells isolated from the esophagus (Figure 5A) or small
bowel (Figure 5C) of an Ndfip1-cKO mouse. Furthermore,
elevated percentages of eosinophils in these tissues were observed
in all Ndfip1-cKO animals under investigation (Figure 5B and D).
Additionally, all Ndfip1-cKO mice examined demonstrated a
substantial increase in the percentages of activated T cells in their
spleens after this course of antibiotic treatment (Figure 5E and F).
The percentages observed were similar to those percentages in
untreated 5 week old Ndfip1-cKO mice. Thus, we do not see any
decrease in the inflammatory phenotype of Ndfip1-cKO mice
treated with antibiotics from birth until five weeks of age.
Therefore, starting the antibiotic treatment at birth and treating
mice until 5 weeks of age did not improve T cell activation or
inflammation in Ndfip1-cKO mice.
Discussion
In this study, we found that treatment of Ndfip1-cKO mice with
oral antibiotics did not significantly reduce T cell activation or
gastrointestinal eosinophilia and inflammation. No discernible
decrease in T-cell activation or eosinophil infiltration was seen in
Ndfip1-cKO mice regardless of whether they were treated with
antibiotics for two weeks, from 3–5 weeks of age, or treated from
birth to 5 weeks of age. This was true despite the efficacy of
antibiotic treatment in reducing the total GI bacterial load by
more than 100 fold. These results suggest that gut microbiota do
not play a significant role in the development of GI inflammation
in Ndfip1-cKO mice.
Microbiota are known to influence many aspects of immune
function [10,11,12]. In a study using oral gavage to administer a
similar regimen of antibiotics to WT mice, Hill et al. [13]
demonstrated that a ten-fold reduction of 16S rDNA in stool. This
decrease in GI microbiota correlated with reduced production of
IL-17, a cytokine associated with specific types of bacteria
[14,15,16], by intestinal CD4+ T cells. Our antibiotic treatment
reduced the number of bacterial 16S rDNA copies detected in
stool by over 100-fold after two weeks. Given the drastic reduction
in total bacterial load after antibiotic treatment, we consider it
unlikely that any remaining bacteria would provide sufficient
antigenic stimulation of the immune system to induce inflamma-
tion in Ndfip1 cKO mice. While it remains possible that some
Figure 3. Ndfip1 CD4-cKO mice treated with antibiotics for 2 weeks do not show decreased eosinophilia or reduced inflammation
in the esophagus. (A) The average 16s rDNA copies/nanogram of total stool DNA was quantified by qPCR at day 0 and day 13 of treatment with
sucralose alone (n=5) or sucralose and antibiotics (n=4). Error bars illustrate SD. (B) Weights of mice treated with sucralose alone (2ABX=solid line)
or antibiotics and sucralose (+ABX=dashed line) over the course of the 13 day treatment. (C) Representative H & E stained histological sections of the
esophagus and small bowel of Ndfip1-cKO mice after 13 days of treatment with sucralose alone or antibiotics and sucralose are shown. (D)
Percentages of activated CD4+ T cells in the spleens of mice treated with sucralose only (untreated) or with antibiotics and sucralose (treated) as
determined by flow cytometric analysis. Each dot represents a single mouse.
doi:10.1371/journal.pone.0034478.g003
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gut, the ,100 fold decrease in bacterial load did not correlate with
any discernable decrease in the percentages of activated T cells in
Ndfip1-cKO mice. This leads us to conclude that few, if any,
Ndfip12/2 T cells are activated by bacterial antigens. Thus, the
activation of T cells lacking Ndfip1 must be caused by other self-
or environmental-antigens.
Our study shows that the gastrointestinal microbiota do not play
a significant role in the development of GI inflammation in
Ndfip1-cKO animals, it is possible that other types of environ-
mental antigens are responsible for inflammation in Ndfip1-
Figure 4. Ndfip1 CD4-cKO mice treated with antibiotics from birth do not show changes in eosinophilia or inflammation in the
esophagus, or splenic T cell activation. (A) Weights of control mice (n=4) (closed circles) or Ndfip1-cKO mice(n=4) (open circles) between
weeks 3 to 5 of antibiotic treatment. (B) H & E stains of histological sections of esophagus taken from control and Ndfip1-cKO mice after antibiotic
treatment from birth to 5 weeks. Images were taken using a 206objective. Inset of panel outlined by the box is shown in the images on the right.
doi:10.1371/journal.pone.0034478.g004
Figure 5. Antibiotic Treatment of Ndfip1 cKOs from Birth Does Not Reduce Inflammation. (A–D) Representative flow cytometry plots of
cells isolated from the esophagus (A) and small bowel (C) of Ndfip1-cKO and control animals treated from birth to 5 weeks. Graphs of the percentages
of eosinophils (Siglec F+) and CD4+ T cells in esophagus (B) or small bowel (D) from all mice in the experiment are shown. (E) Representative flow
plots illustrating the percentage of activiated cells among splenic CD4+ gated T cells. (F) Percentages of activated T cells in the spleens of all mice
treated with antibiotics from birth to 5 weeks are shown.
doi:10.1371/journal.pone.0034478.g005
Inflammation in Ndfip12/2 Is Not Due to Microbiota
PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e34478deficient mice. In addition to bacterial-derived antigens, food
antigens have also been implicated in the pathogenesis of IBD
[11]. Supporting this, food restriction diets have been shown to
improve IBD symptoms in human patients and in animal models
[12,13,14].
Food antigens are also associated with other eosinophilic GI
disorders. Eosinophilic gastrointestinal disorders (EGID) are
chronic diseases characterized by increased numbers of eosinophils
in the digestive tract. These disorders, all of which are associated
with food allergy, include eosinophilic esophagitis (EoE), eosino-
philic gastritis (EG) and gastroenteritis (EGE), and eosinophilic
colitis (EC). Because of its association with food allergy, diet has
been used to treat patients with EoE [15–16]. The high degree of
esophageal inflammation, revealed by eosinophilia and epithelial
hypertrophy, in Ndfip1-cKO animals bears a strong resemblance
to the pathology of EoE and EGE. Thus, Ndfip1-cKO mice may
serve as a model for these disorders. This is of particular
significance since patients with EoE commonly have other allergic
diseases such as asthma and atopic dermatitis. Mice lacking Ndfip1
also develop atopic inflammation in the skin and lung. This might
suggest that, like with patients with EoE, eosinophilia and GI
inflammation in Ndfip12/2 mice is caused by aberrant immune
responses to food antigens. Experiments are currently underway in
our lab to test this hypothesis.
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